The significance of early detection of age-related macular degeneration

被引:38
作者
Loewenstein, Anat [1 ]
机构
[1] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Fac Med, Dept Ophthalmol, IL-64239 Tel Aviv, Israel
来源
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2007年 / 27卷 / 07期
关键词
age-related macular degeneration (AMD); choroidal neovascularization (CNV); early detection; progressive; subfoveal;
D O I
10.1097/IAE.0b013e318050d2ec
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: The main cause for visual loss in age-related macular degeneration (AMD) is the development of choroidal neovascularization (CNV), which has been shown to occur in 18% of patients over 5 years. Even though satisfactory treatments for CNV are available, in the majority of cases no improvement in visual acuity occurs and in those it does it is mostly limited. Early detection has the potential of significantly improving the final visual outcome of patients who develop subfoveal CNIV. Methods: This review is a summary of the importance of early detection in the management of AMD, in view of the current available treatment methods. It is a review of the results of early detection of AMD using the Preferential Hyperacuity Perimeter (PHP). Results: Awareness for symptoms, use of the Amsler grid and monitoring by an ophthalmologist are not satisfactory means for early detection of AMD. The PHP has good sensitivity and specificity in detecting CNV patient early and differentiate them from intermediate AMD. Conclusion: In an era of excellent treatments available for CNV treatment, early detection of CNV by novel technology modalities such as the PHP at a frequency that allows early detection (similar to 4 times a year) is crucial in the armamentarium of AMD patient management.
引用
收藏
页码:873 / 878
页数:6
相关论文
共 32 条
[1]   ROLE OF THE COMPLETION PHENOMENON IN THE EVALUATION OF AMSLER GRID RESULTS [J].
ACHARD, OA ;
SAFRAN, AB ;
DURET, FC ;
RAGAMA, E .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1995, 120 (03) :322-329
[2]   Preferential hyperacuity perimeter (PreView PHP) for detecting choroidal neovascularization study [J].
Alster, Y ;
Bressler, NM ;
Bressler, SB ;
Brimacombe, JA ;
Crompton, RM ;
Duh, YJ ;
Gabel, VP ;
Heier, JS ;
Ip, MS ;
Loewenstein, A ;
Packo, KH ;
Stur, M ;
Toaff, T .
OPHTHALMOLOGY, 2005, 112 (10) :1758-1765
[3]   Knowledge and beliefs about common eye diseases [J].
Attebo, K ;
Mitchell, P ;
Cumming, R ;
Smith, W .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF OPHTHALMOLOGY, 1997, 25 (04) :283-287
[4]   Vision-related quality of life in patients suffering from age-related macular degeneration [J].
Berdeaux, GH ;
Nordmann, JP ;
Colin, E ;
Arnould, B .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 139 (02) :271-279
[5]   Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1 [J].
Blinder, KJ ;
Bradley, S ;
Bressler, NM ;
Bressler, SB ;
Donati, G ;
Hao, Y ;
Ma, C ;
Menchini, U ;
Miller, J ;
Potter, MJ ;
Pournaras, JC ;
Reaves, A ;
Rosenfeld, PJ ;
Strong, HA ;
Stur, M ;
Su, XY ;
Virgili, G .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (03) :407-418
[6]   Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration [J].
Boyer, David S. ;
Antoszyk, Andrew N. ;
Awh, Carl C. ;
Bhisitkul, Robert B. ;
Shapiro, Howard ;
Acharya, Nisha R. .
OPHTHALMOLOGY, 2007, 114 (02) :246-252
[7]   NATURAL COURSE OF POORLY DEFINED CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH MACULAR DEGENERATION [J].
BRESSLER, NM ;
FROST, LA ;
BRESSLER, SB ;
MURPHY, RP ;
FINE, SL .
ARCHIVES OF OPHTHALMOLOGY, 1988, 106 (11) :1537-1542
[8]   Ranibizumab versus verteporfin for neovascular age-related macular degeneration [J].
Brown, David M. ;
Kaiser, Peter K. ;
Michels, Mark ;
Soubrane, Gisele ;
Heier, Jeffrey S. ;
Kim, Robert Y. ;
Sy, Judy P. ;
Schneider, Susan .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1432-1444
[9]  
BURGESS DB, 1993, ARCH OPHTHALMOL-CHIC, V111, P1189
[10]   Monitoring the patient after treatment: angiographic aspects of recurrence and indications for retreatment [J].
Coscas, G ;
Coscas, F ;
Soubrane, G .
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2004, 27 (01) :81-92